Search the Newsreel

Precipio, Inc. (PRPO) grows Q2 2026 revenue 24% amid going concern warning

Precipio Inc (PRPO) Stock News Today

This article provides current stock news for Precipio Inc (PRPO). As of the article's publication, PRPO's stock is trading at $23.970, up +2.17%, with a market cap of 42.75M USD. The article notes that more news is expected soon regarding the company.

(PRPO) Movement as an Input in Quant Signal Sets

This article analyzes Precipio Inc. (NASDAQ: PRPO) using AI models to generate trading strategies across different risk profiles. Key findings indicate divergent sentiment, suggesting choppy conditions, and highlights support and resistance levels. The analysis provides specific entry, target, and stop-loss zones for position trading, …

Precipio Schedules Q2 2026 Shareholder Update Call

Precipio (PRPO) announced it will host its Q2 2026 shareholder update call on August 17, 2026, at 5:00 p.m. ET to discuss performance in its cancer diagnostics businesses. CEO Ilan Danieli will provide remarks on progress and engage in a live Q&A session. TipRanks' …

Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis

Precipio Inc (PRPO) has a weak financial status with a score of 4.51, ranking 199 out of 200 in its industry. Despite this, the company reported a significant year-over-year revenue increase of 36.15% and a net profit increase of 63.24% in its latest quarter. …

Precipio (NASDAQ: PRPO) plans Q2 2026 shareholder call with live Q&A

Precipio, Inc. (NASDAQ: PRPO) announced it will host a Q2-2026 shareholder update call on August 17, 2026, at 5:00 PM ET. The call will cover updates on the company's core businesses and include a live moderated Q&A session. CEO Ilan Danieli expressed optimism about …

Precipio Inc. Q2 Results: Shareholder update call set for August 17

Precipio Inc. has scheduled its Q2-2026 shareholder update call for August 17, 2026, at 5:00 PM ET. CEO Ilan Danieli will discuss core business updates and progress in customer acquisition and pipeline expansion. Investors can participate in a live Q&A session or submit questions …

Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Precipio Inc (PRPO), detailing its current risk score of 2.96 within the Healthcare Equipment & Supplies industry. It highlights the company's beta value of 1.33, indicating higher volatility compared to the S&P 500. The assessment also covers …

Precipio Inc (PRPO) Institutional Confidence

This article analyzes the institutional confidence score for Precipio Inc (PRPO), which stands at 3.00, ranking 130 out of 199 in its industry. The institutional shareholding proportion is 19.15%, showing a slight decrease. James Simons is identified as the largest institutional shareholder, with other …

Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Precipio Inc (PRPO), noting its current valuation score of 8.08 within the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -50.70, which is significantly below its recent high but above its recent low. …

PRPO|Precipio Inc|Price:23.490|Chg%:-0.190

Precipio Inc (PRPO) has a TradingKey Stock Score indicating stable fundamentals, significant growth potential, and high institutional ownership, despite an expected medium-term stock price decline. The biotechnology company focuses on cancer diagnostics with technologies like HemeScreen and IV-Cell, showing strong revenue growth and increased …

Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Precipio Inc (PRPO), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, including hedge funds, individual investors, and investment advisors, alongside historical institutional shareholding data and recent shareholder activity. The information is …

Precipio Inc (PRPO) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Precipio Inc (PRPO), covering operating, investing, and financing activities. It also includes an FAQ section explaining different types of cash flow and Precipio Inc's performance in each category, highlighting figures like operating …

Precipio Inc (PRPO) Income Statement

This article provides a detailed quarterly and annual income statement for Precipio Inc (PRPO), offering insights into its revenue, operating expenses, net income, and earnings per share. It covers financial data extending from FY2012Q1 through FY2026Q1, highlighting key metrics like total revenue, cost of …

Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Precipio Inc (PRPO), detailing future EPS and revenue growth estimates. It includes a snapshot of PRPO's stock performance, market capitalization, and a breakdown of TradingKey's stock score components such as financial health, valuation, earnings forecast, price momentum, …

Precipio Announces Q1-2026 Shareholder Update Call

Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, announced it will host its Q1-2026 shareholder update call on May 18th, 2026, at 5:00 PM ET. The call will cover the company's core businesses and include a moderated live Q&A session for the first …

Precipio, Inc. Revenue Breakdown – NASDAQ:PRPO

This article provides a brief overview of Precipio, Inc.'s revenue breakdown. The company's primary revenue contribution comes from the United States, generating $24.05 million last year, up from $18.53 million the previous year. The data presented focuses on top segments and regional performance.

Liquidity Mapping Around (PRPO) Price Events

Quantitative analysis for Precipio Inc. (NASDAQ: PRPO) indicates weak near and mid-term sentiment, despite a strong long-term outlook. The report highlights elevated downside risk due to a lack of additional long-term support signals and provides institutional trading strategies for long, breakout, and short positions …

Form 4 Precipio Inc For: 16 July By Investing.com

This article announces a Form 4 filing for Precipio Inc., dated July 16, as reported by Investing.com. It is a brief notification with a link to regulatory details. The content also showcases various market data and other news headlines common to the Investing.com platform.

Precipio, Inc. (PRPO) director takes stock in lieu of cash pay

Precipio, Inc. Director David Seth Cohen received 520 shares of common stock on July 15, 2026, as compensation for his Q2-26 board service, totaling $13K. This grant, valued at $25.24 per share, was issued in lieu of a cash payment and increased his direct …

Precipio (PRPO) director receives 108-share stock grant for Q2-26 service

Precipio, Inc. director Christina Rizopoulos received a grant of 108 shares of common stock on July 15, 2026, as compensation for her Board service during Q2-26. The shares were valued at $25.24 each and were issued in lieu of a cash payment. Following this …

Precipio, Inc. (PRPO) director gets 416-share stock grant for Q2 board fees

Precipio, Inc. director Jeffrey Cossman received a grant of 416 shares of common stock on July 15, 2026, as compensation for his Q2-26 Board of Directors service. This equity award, valued at $25.24 per share, increased his direct holdings to 16,549 common shares. The …